gemcitabine has been researched along with ribociclib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afratis, K; Gavras, H; Karamanos, NK; Koutsakis, C; Leonardi, S; Papaioannou, D; Piperigkou, Z; Rassias, G; Rigopoulou, D; Vachlioti, E | 1 |
| Campagne, O; Jonchere, B; Liu, J; Northcott, PA; Onar-Thomas, A; Patel, Y; Pribnow, A; Robinson, GW; Robinson, S; Roussel, MF; Smith, KS; Stewart, CF; Wu, G; Xu, K; Yu, J | 1 |
| Farmer, DM; Freeman, BB; Jonchere, B; Liu, J; Min, J; Rankovic, Z; Robinson, S; Roussel, MF; Shelat, AA; Stripay, JL; Wang, Y; Williams, J; Yang, L; Yu, J; Zindy, F | 1 |
3 other study(ies) available for gemcitabine and ribociclib
| Article | Year |
|---|---|
Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved?
Topics: Anti-Bacterial Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; MCF-7 Cells; Quinolines; Receptor, Bradykinin B2 | 2021 |
Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma.
Topics: Aminopyridines; Animals; Cerebellar Neoplasms; Child; Deoxycytidine; Gemcitabine; Humans; Medulloblastoma; Mice; Purines | 2022 |
Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo.
Topics: Animals; Cerebellar Neoplasms; Gemcitabine; Hedgehog Proteins; Humans; Mechanistic Target of Rapamycin Complex 1; Medulloblastoma; Mice; MTOR Inhibitors; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2023 |